Sino Biopharmaceutical
Internal AI knowledge libraries for pharmaceutical staff
Sino Biopharmaceutical opened internal AI knowledge libraries covering more than 10,000 documents
Problem
Employees needed access to specialist information held in internal documents and external pharmaceutical sources.
Approach
The group built knowledge libraries using local knowledge engines and cloud collaboration. Semantic search and intelligent question answering supported retrieval, with access permissions controlling which material employees could use. The first libraries were open internally by March 2025.
Results
Takeaway
The initial deployment made specialist material searchable within employee access permissions. Sino Biopharmaceutical did not disclose measured time savings.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Internal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
The company said its first AI knowledge libraries were available internally. It described more than 10,000 integrated documents, semantic retrieval and permission-controlled access, without measured productivity results.
Full details are in the original sources.